Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation M Mahmoudian, H Valizadeh, P Zakeri-Milani Drug development and industrial pharmacy 44 (10), 1598-1605, 2018 | 36 | 2018 |
Stabilization and anticancer enhancing activity of the peptide nisin by cyclodextrin-based nanosponges against colon and breast cancer cells Y Khazaei Monfared, M Mahmoudian, C Cecone, F Caldera, ... Polymers 14 (3), 594, 2022 | 34 | 2022 |
Natural low-and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery M Mahmoudian, S Salatin, AY Khosroushahi Cancer chemotherapy and pharmacology 82, 371-382, 2018 | 33 | 2018 |
Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery S Allahyari, H Valizadeh, L Roshangar, M Mahmoudian, F Trotta, ... Expert Opinion on Drug Delivery 17 (12), 1807-1816, 2020 | 31 | 2020 |
Safety and toxicity issues of therapeutically used nanoparticles from the oral route F Lotfipour, S Shahi, A Farjami, S Salatin, M Mahmoudian, SM Dizaj BioMed Research International 2021 (1), 9322282, 2021 | 20 | 2021 |
Enhancement of the intestinal absorption of bortezomib by self-nanoemulsifying drug delivery system M Mahmoudian, H Valizadeh, R Löbenberg, P Zakeri-Milani Pharmaceutical development and technology 25 (3), 351-358, 2020 | 19 | 2020 |
Nisin delivery by nanosponges increases its anticancer activity against in-vivo melanoma model YK Monfared, M Mahmoudian, F Caldera, AR Pedrazzo, P Zakeri-Milani, ... Journal of Drug Delivery Science and Technology 79, 104065, 2023 | 12 | 2023 |
Oral delivery of solid lipid nanoparticles: Underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate M Mahmoudian, S Maleki Dizaj, S Salatin, R Löbenberg, M Saadat, ... Expert Opinion on Drug Delivery 18 (11), 1707-1722, 2021 | 12 | 2021 |
Bortezomib-loaded lipidic-nano drug delivery systems; formulation, therapeutic efficacy, and pharmacokinetics M Mahmoudian, H Valizadeh, R Löbenberg, P Zakeri-Milani Journal of microencapsulation 38 (3), 192-202, 2021 | 10 | 2021 |
Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells P Zakeri-Milani, A Shirani, A Nokhodchi, S Mussa Farkhani, ... Drug Development and Industrial Pharmacy 46 (4), 521-530, 2020 | 10 | 2020 |
Investigating intestinal permeability of bortezomib using a validated HPLC-UV method M Mahmoudian, P Zakeri-Milani, H Valizadeh Drug research 69 (03), 130-135, 2019 | 10 | 2019 |
Cyclodextrin-Based Nanosponges as Perse Antimicrobial Agents Increase the Activity of Natural Antimicrobial Peptide Nisin Y Khazaei Monfared, M Mahmoudian, G Hoti, F Caldera, ... Pharmaceutics 14 (3), 685, 2022 | 9 | 2022 |
Oral supplementation of solvent-free kynurenic acid/cyclodextrin nanosponges complexes increased its bioavailability YK Monfared, AR Pedrazzo, M Mahmoudian, F Caldera, P Zakeri-Milani, ... Colloids and Surfaces B: Biointerfaces 222, 113101, 2023 | 8 | 2023 |
Synthesis and preparation of vitamin A coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats S Mahdinloo, S Hemmati, H Valizadeh, M Mahmoudian, J Mahmoudi, ... International Journal of Pharmaceutics 625, 122063, 2022 | 8 | 2022 |
Surface modification with cholesteryl acetyl carnitine, a novel cationic agent, elevates cancer cell uptake of the PEGylated liposomes F Zahednezhad, JS Mojarrad, P Zakeri-Milani, B Baradaran, ... International Journal of Pharmaceutics 609, 121148, 2021 | 8 | 2021 |
The Factors Determining the Skin Penetration and Cellular Uptake of Nanocarriers: New Hope for Clinical Development A Farjami, S Salatin, S Jafari, M Mahmoudian, M Jelvehgari Current pharmaceutical design 27 (42), 4315-4329, 2021 | 8 | 2021 |
Hyper-branched cationic cyclodextrin polymers for improving plasmid transfection in 2D and 3D spheroid cells YK Monfared, M Mahmoudian, C Cecone, F Caldera, S Haiaty, ... Pharmaceutics 14 (12), 2690, 2022 | 7 | 2022 |
The therapeutic benefits of intravenously administrated nanoparticles in stroke and age-related neurodegenerative diseases M Farhoudi, S Sadigh-Eteghad, J Mahmoudi, A Farjami, M Mahmoudian, ... Current Pharmaceutical Design 28 (24), 1985-2000, 2022 | 6 | 2022 |
Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles F Mostafaei, S Hemmati, H Valizadeh, M Mahmoudian, M Sarfraz, M Abdi, ... International Journal of Pharmaceutics 649, 123635, 2024 | 3 | 2024 |
Acetyl carnitine modified liposomes elevate cisplatin uptake in macrophage and cancer cells F Zahednezhad, P Zakeri-Milani, JS Mojarrad, M Sarfraz, M Mahmoudian, ... Journal of Drug Delivery Science and Technology 81, 104198, 2023 | 3 | 2023 |